UBS Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.78M | Buy |
257,170
+132,505
| +106% | +$1.02M | ﹤0.01% | 5086 |
|
|
2025
Q4 | $1.1M | Sell |
124,665
-1,451
| -1% | -$7.99K | ﹤0.01% | 5480 |
|
|
2025
Q3 | $629K | Buy |
126,116
+56,272
| +81% | +$261K | ﹤0.01% | 5915 |
|
|
2025
Q2 | $330K | Sell |
69,844
-17,742
| -20% | -$77.6K | ﹤0.01% | 6368 |
|
|
2025
Q1 | $402K | Sell |
87,586
-142,351
| -62% | -$664K | ﹤0.01% | 6025 |
|
|
2024
Q4 | $1.1M | Buy |
229,937
+143,056
| +165% | +$687K | ﹤0.01% | 5228 |
|
|
2024
Q3 | $407K | Buy |
86,881
+8,471
| +11% | +$45.4K | ﹤0.01% | 5375 |
|
|
2024
Q2 | $443K | Buy |
78,410
+12,012
| +18% | +$62K | ﹤0.01% | 5092 |
|
|
2024
Q1 | $273K | Sell |
66,398
-9,213
| -12% | -$36.9K | ﹤0.01% | 5642 |
|
|
2023
Q4 | $319K | Sell |
75,611
-16,575
| -18% | -$66.9K | ﹤0.01% | 5453 |
|
|
2023
Q3 | $398K | Sell |
92,186
-39,519
| -30% | -$220K | ﹤0.01% | 4837 |
|
|
2023
Q2 | $868K | Sell |
131,705
-2,206
| -2% | -$14.1K | ﹤0.01% | 4371 |
|
|
2023
Q1 | $909K | Sell |
133,911
-4,987
| -4% | -$35.1K | ﹤0.01% | 4206 |
|
|
2022
Q4 | $1.03M | Buy |
138,898
+91,895
| +196% | +$895K | ﹤0.01% | 4044 |
|
|
2022
Q3 | $464K | Sell |
47,003
-10,740
| -19% | -$113K | ﹤0.01% | 4404 |
|
|
2022
Q2 | $630K | Sell |
57,743
-74,743
| -56% | -$774K | ﹤0.01% | 4083 |
|
|
2022
Q1 | $1.5M | Buy |
132,486
+77,578
| +141% | +$1.02M | ﹤0.01% | 3715 |
|
|
2021
Q4 | $861K | Buy |
54,908
+5,284
| +11% | +$92.1K | ﹤0.01% | 4526 |
|
|
2021
Q3 | $850K | Buy |
49,624
+46,923
| +1,737% | +$822K | ﹤0.01% | 4330 |
|
|
2021
Q2 | $58K | Sell |
2,701
-71,063
| -96% | -$1.27M | ﹤0.01% | 6307 |
|
|
2021
Q1 | $1.11M | Buy |
73,764
+9,274
| +14% | +$150K | ﹤0.01% | 4148 |
|
|
2020
Q4 | $847K | Buy |
64,490
+54,379
| +538% | +$655K | ﹤0.01% | 4153 |
|
|
2020
Q3 | $98K | Sell |
10,111
-15,748
| -61% | -$168K | ﹤0.01% | 5197 |
|
|
2020
Q2 | $296K | Buy |
25,859
+23,304
| +912% | +$264K | ﹤0.01% | 4528 |
|
|
2020
Q1 | $26K | Sell |
2,555
-72,624
| -97% | -$900K | ﹤0.01% | 6333 |
|
|
2019
Q4 | $1.23M | Sell |
75,179
-4,209
| -5% | -$63.6K | ﹤0.01% | 4009 |
|
|
2019
Q3 | $1.05M | Buy |
79,388
+73,046
| +1,152% | +$1.02M | ﹤0.01% | 3922 |
|
|
2019
Q2 | $90K | Sell |
6,342
-600
| -9% | -$9.55K | ﹤0.01% | 5448 |
|
|
2019
Q1 | $127K | Sell |
6,942
-163,504
| -96% | -$3.73M | ﹤0.01% | 4911 |
|
|
2018
Q4 | $4.45M | Buy |
170,446
+144,907
| +567% | +$3.41M | ﹤0.01% | 2258 |
|
|
2018
Q3 | $586K | Buy |
25,539
+15,460
| +153% | +$316K | ﹤0.01% | 4305 |
|
|
2018
Q2 | $192K | Sell |
10,079
-74,660
| -88% | -$1.25M | ﹤0.01% | 4972 |
|
|
2018
Q1 | $1.43M | Buy |
84,739
+22,382
| +36% | +$375K | ﹤0.01% | 3407 |
|
|
2017
Q4 | $947K | Sell |
62,357
-66,748
| -52% | -$991K | ﹤0.01% | 3833 |
|
|
2017
Q3 | $2.31M | Buy |
129,105
+114,667
| +794% | +$1.92M | ﹤0.01% | 2998 |
|
|
2017
Q2 | $235K | Buy |
14,438
+2,618
| +22% | +$37.7K | ﹤0.01% | 4653 |
|
|
2017
Q1 | $165K | Sell |
11,820
-29,878
| -72% | -$426K | ﹤0.01% | 4758 |
|
|
2016
Q4 | $666K | Buy |
41,698
+22,586
| +118% | +$363K | ﹤0.01% | 3896 |
|
|
2016
Q3 | $319K | Sell |
19,112
-16,237
| -46% | -$219K | ﹤0.01% | 4220 |
|
|
2016
Q2 | $396K | Buy |
35,349
+10,563
| +43% | +$102K | ﹤0.01% | 4068 |
|
|
2016
Q1 | $207K | Sell |
24,786
-113,560
| -82% | -$932K | ﹤0.01% | 4470 |
|
|
2015
Q4 | $1.29M | Buy |
138,346
+109,346
| +377% | +$1.09M | ﹤0.01% | 3195 |
|
|
2015
Q3 | $327K | Buy |
29,000
+222
| +0.8% | +$2.71K | ﹤0.01% | 4239 |
|
|
2015
Q2 | $366K | Buy |
28,778
+25,278
| +722% | +$273K | ﹤0.01% | 4372 |
|
|
2015
Q1 | $32K | Buy |
3,500
+1,500
| +75% | +$16.9K | ﹤0.01% | 6489 |
|
|
2014
Q4 | $29K | Buy |
+2,000
| New | +$23.7K | ﹤0.01% | 7151 |
|
Other funds holding VNDA
ACM
VCM
